These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28092019

  • 1. URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors.
    Escamilla-Ramírez A, García E, Palencia-Hernández G, Colín-González AL, Galván-Arzate S, Túnez I, Sotelo J, Santamaría A.
    Neurotox Res; 2017 May; 31(4):532-544. PubMed ID: 28092019
    [Abstract] [Full Text] [Related]

  • 2. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, Strong R, Lutz B, Marsicano G, Roberts JL, Giuffrida A.
    Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 4. Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage.
    Viveros-Paredes JM, Gonzalez-Castañeda RE, Escalante-Castañeda A, Tejeda-Martínez AR, Castañeda-Achutiguí F, Flores-Soto ME.
    Neurologia (Engl Ed); 2019 Apr; 34(3):143-152. PubMed ID: 28104279
    [Abstract] [Full Text] [Related]

  • 5. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 6. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain.
    Rangel-López E, Colín-González AL, Paz-Loyola AL, Pinzón E, Torres I, Serratos IN, Castellanos P, Wajner M, Souza DO, Santamaría A.
    Neuroscience; 2015 Jan 29; 285():97-106. PubMed ID: 25446347
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors.
    Maya-López M, Colín-González AL, Aguilera G, de Lima ME, Colpo-Ceolin A, Rangel-López E, Villeda-Hernández J, Rembao-Bojórquez D, Túnez I, Luna-López A, Lazzarini-Lechuga R, González-Puertos VY, Posadas-Rodríguez P, Silva-Palacios A, Königsberg M, Santamaría A.
    Am J Transl Res; 2017 Jan 29; 9(2):261-274. PubMed ID: 28337258
    [Abstract] [Full Text] [Related]

  • 9. URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats.
    Maya-López M, Ruiz-Contreras HA, de Jesús Negrete-Ruíz M, Martínez-Sánchez JE, Benítez-Valenzuela J, Colín-González AL, Villeda-Hernández J, Sánchez-Chapul L, Parra-Cid C, Rangel-López E, Santamaría A.
    Biomed Pharmacother; 2017 Apr 29; 88():745-753. PubMed ID: 28157650
    [Abstract] [Full Text] [Related]

  • 10. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
    Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J.
    Behav Brain Res; 2016 Oct 15; 313():334-344. PubMed ID: 27424778
    [Abstract] [Full Text] [Related]

  • 11. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA, Xu Z, Mali SS, Hohmann AG.
    Pharmacol Res; 2019 Apr 15; 142():267-282. PubMed ID: 30739035
    [Abstract] [Full Text] [Related]

  • 12. The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation.
    Aguilera-Portillo G, Rangel-López E, Villeda-Hernández J, Chavarría A, Castellanos P, Elmazoglu Z, Karasu Ç, Túnez I, Pedraza G, Königsberg M, Santamaría A.
    Mol Neurobiol; 2019 Feb 15; 56(2):844-856. PubMed ID: 29802570
    [Abstract] [Full Text] [Related]

  • 13. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 15; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 14. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 15; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 15. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 16. The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes.
    Colín-González AL, Paz-Loyola AL, Serratos IN, Seminotti B, Ribeiro CA, Leipnitz G, Souza DO, Wajner M, Santamaría A.
    Neuroscience; 2015 Dec 03; 310():578-88. PubMed ID: 26431622
    [Abstract] [Full Text] [Related]

  • 17. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR, Duranti A, Nobrega JN, Gobbi G.
    Eur Neuropsychopharmacol; 2016 Mar 03; 26(3):578-90. PubMed ID: 26747370
    [Abstract] [Full Text] [Related]

  • 18. Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.
    Kupsch A, Löschmann PA, Sauer H, Arnold G, Renner P, Pufal D, Burg M, Wachtel H, ten Bruggencate G, Oertel WH.
    Brain Res; 1992 Oct 02; 592(1-2):74-83. PubMed ID: 1360317
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
    Fanarioti E, Mavrikaki M, Panagis G, Mitsacos A, Nomikos GG, Giompres P.
    Int J Neuropsychopharmacol; 2014 Dec 07; 18(6):. PubMed ID: 25522428
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL, Qu R, Zhang J, Li LF, Ma SP.
    Fitoterapia; 2013 Oct 07; 90():112-8. PubMed ID: 23876367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.